Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2024

13-01-2024 | Tympanotomy | Invited Commentary

Optimizing Outcomes in Patients with Ascites Complicating Cirrhosis—Maximizing the Hour of Power

Authors: Stephanie Y. Tsai, Jacqueline G. O’Leary

Published in: Digestive Diseases and Sciences | Issue 4/2024

Login to get access

Excerpt

Acutely hospitalized patients with decompensated cirrhosis complicated by ascites are at increased risk for spontaneous bacterial peritonitis (SBP), the most common infection in this population, that is asymptomatic in up to one-third of patients [13]. Diagnostic paracentesis is thus recommended on admission as an AASLD quality metric in this population, a procedure that in theory is easy to accomplish due to minimal training requirements, low complication rate, and the lack of need for pre-procedure coagulation studies [25]. Furthermore, early paracentesis (< 1 day after admission) decreases the risk of acute kidney injury (AKI), intensive care unit (ICU) transfer, length of stay, and inpatient mortality [57]. Moreover, diagnostic paracentesis prior to administration of antibiotics can help identify causative microorganisms, guide tailored therapy, combat the rising prevalence of multidrug-resistant organisms (MDROs) by avoiding antibiotics in patients without SBP, and appropriately identify patients who need secondary SBP prophylaxis. Unfortunately, diagnostic paracentesis may be declining in frequency in this population, especially in hospitals run by the US Department of Veterans Affairs [3, 5]. …
Literature
2.
go back to reference Biggins SW, Angeli P, Garcia-Tsao G, Gines P, Ling SC, Nadim MK, Wong F et al. Diagnosis, Evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;74:1014–1048.CrossRefPubMed Biggins SW, Angeli P, Garcia-Tsao G, Gines P, Ling SC, Nadim MK, Wong F et al. Diagnosis, Evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;74:1014–1048.CrossRefPubMed
3.
go back to reference Kanwal F, Tapper EB, Ho C, Asrani SK, Ovchinsky N, Poterucha J, Flores A et al. Development of quality measures in cirrhosis by the practice metrics committee of the American Association for the study of liver diseases. Hepatology 2019;69:1787–1797.CrossRefPubMed Kanwal F, Tapper EB, Ho C, Asrani SK, Ovchinsky N, Poterucha J, Flores A et al. Development of quality measures in cirrhosis by the practice metrics committee of the American Association for the study of liver diseases. Hepatology 2019;69:1787–1797.CrossRefPubMed
4.
go back to reference Runyon BA, Committee APG. Management of adult patients with ascites due to cirrhosis: an update. Hepatology 2009;49:2087–2107.CrossRefPubMed Runyon BA, Committee APG. Management of adult patients with ascites due to cirrhosis: an update. Hepatology 2009;49:2087–2107.CrossRefPubMed
5.
go back to reference Patel N, Silvey S, O’Leary JG, Morgan T, Patton H, Rogal SS, Bajaj JS. Early paracentesis is associated with better prognosis compared with late or no-paracentesis in hospitalized veterans with cirrhosis and ascites. Liver Transpl 2023;29:919–927.CrossRefPubMed Patel N, Silvey S, O’Leary JG, Morgan T, Patton H, Rogal SS, Bajaj JS. Early paracentesis is associated with better prognosis compared with late or no-paracentesis in hospitalized veterans with cirrhosis and ascites. Liver Transpl 2023;29:919–927.CrossRefPubMed
6.
go back to reference Orman Eric S, Hayashi Paul H, Ramon Bataller A, Barritt Sidney. Paracentesis is associated with reduced mortality in patients hospitalized with cirrhosis and ascites. Clin Gastroenterol Hepatol 2014;12:496–503491.CrossRefPubMed Orman Eric S, Hayashi Paul H, Ramon Bataller A, Barritt Sidney. Paracentesis is associated with reduced mortality in patients hospitalized with cirrhosis and ascites. Clin Gastroenterol Hepatol 2014;12:496–503491.CrossRefPubMed
7.
go back to reference Kim JJ, Tsukamoto MM, Mathur AK, Ghomri YM, Hou LA, Sheibani S, Runyon BA. Delayed paracentesis is associated with increased in-hospital mortality in patients with spontaneous bacterial peritonitis. Am J Gastroenterol 2014;109:1436–1442.CrossRefPubMed Kim JJ, Tsukamoto MM, Mathur AK, Ghomri YM, Hou LA, Sheibani S, Runyon BA. Delayed paracentesis is associated with increased in-hospital mortality in patients with spontaneous bacterial peritonitis. Am J Gastroenterol 2014;109:1436–1442.CrossRefPubMed
8.
go back to reference Badal J, Badal B, Nawras M, Lee-Smith W, Stanley S, Hassan M. Diagnostic paracentesis within 1 day is associated with reduced mortality and length of hospital stay in patients with cirrhosis and ascites. Dig Dis Sci. (Epub ahead of print). https://doi.org/10.1007/s10620-023-08249-w. Badal J, Badal B, Nawras M, Lee-Smith W, Stanley S, Hassan M. Diagnostic paracentesis within 1 day is associated with reduced mortality and length of hospital stay in patients with cirrhosis and ascites. Dig Dis Sci. (Epub ahead of print). https://​doi.​org/​10.​1007/​s10620-023-08249-w.
9.
go back to reference Piano S, Singh V, Caraceni P, Maiwall R, Alessandria C, Fernandez J, Soares EC et al. Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide. Gastroenterology 2019;156:1368-1380 e1310.CrossRefPubMed Piano S, Singh V, Caraceni P, Maiwall R, Alessandria C, Fernandez J, Soares EC et al. Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide. Gastroenterology 2019;156:1368-1380 e1310.CrossRefPubMed
10.
go back to reference Gupta K, Khan A, Goyal H, Cal N, Hans B, Martins T, Ghaoui R. Weekend admissions with ascites are associated with delayed paracentesis: a nationwide analysis of the ‘weekend effect.’ Ann Hepatol 2020;19:523–529.CrossRefPubMed Gupta K, Khan A, Goyal H, Cal N, Hans B, Martins T, Ghaoui R. Weekend admissions with ascites are associated with delayed paracentesis: a nationwide analysis of the ‘weekend effect.’ Ann Hepatol 2020;19:523–529.CrossRefPubMed
11.
go back to reference Reitz KM, Kennedy J, Li SR, Handzel R, Tonetti DA, Neal MD, Zuckerbraun BS et al. Association between time to source control in sepsis and 90-day mortality. JAMA Surg 2022;157:817–826.CrossRefPubMedPubMedCentral Reitz KM, Kennedy J, Li SR, Handzel R, Tonetti DA, Neal MD, Zuckerbraun BS et al. Association between time to source control in sepsis and 90-day mortality. JAMA Surg 2022;157:817–826.CrossRefPubMedPubMedCentral
12.
go back to reference Seymour CW, Gesten F, Prescott HC, Friedrich ME, Iwashyna TJ, Phillips GS, Lemeshow S et al. Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med 2017;376:2235–2244.CrossRefPubMedPubMedCentral Seymour CW, Gesten F, Prescott HC, Friedrich ME, Iwashyna TJ, Phillips GS, Lemeshow S et al. Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med 2017;376:2235–2244.CrossRefPubMedPubMedCentral
Metadata
Title
Optimizing Outcomes in Patients with Ascites Complicating Cirrhosis—Maximizing the Hour of Power
Authors
Stephanie Y. Tsai
Jacqueline G. O’Leary
Publication date
13-01-2024
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2024
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-023-08255-y

Other articles of this Issue 4/2024

Digestive Diseases and Sciences 4/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine